semaglutide fda approval mash Exciting Phase 3 Data from Novo Nordisk for Patients with Semaglutide as a MASH Treatment:

The hepatoprotective properties of L-carnitine confer clinical value beyond mere transaminase reduction, potentially delaying disease progression by stabilizing mitochondrial function

A study published in The New England Journal of Medicine in February 2021 focusing on the use of semaglutide (sold as Ozempic, Wegovy, and Rybelsus) for weight loss showed that people lost an average of 6.9 kg (or about 15.2 pounds) of body weight at the end of 40 weeks

They do not make a GLP-1 supplement

what's the signal you're going to look for

It is also important for general vitality as it is involved in energy metabolism

See more details Genius Shot Protein Shot Genius Shot delivers 23g of BLG whey, the most amino-acid-dense fraction of whey protein, in a 100-calorie shot you can take anywhere